Abeona Therapeutics ABEO 深 沪
已收盘 12-19 16:00:00 美东时间
5.11
+0.190
+3.86%
华盛通- 最 高5.605
- 今 开4.94
- 成交量 145.03万股
- 最 低 4.53
- 昨 收 4.92
- 总市值 7.51亿
- 52周最高 7.5401
- 市盈率 静 --
- 换手率 0.99%
- 52周最低 3.9328
- 委 比 81.60%
- 总股本 1.47亿
- 历史最高 30.00
- 量 比 1.33
- 振 幅 21.85%
- 历史最低 0.13
- 每 手 1
- 风险率 0.71%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Abeona Therapeutics granted equity awards to five new non-executive employees, totaling up to 11,500 restricted shares, vesting annually over three years.
06-02 11:30
Abeona Therapeutics® to Present at the Jefferies Global Healthcare Conference
Abeona Therapeutics Inc. announced that its CEO, Vish Seshadri, Ph.D., and CCO, Madhav Vasanthavada, Ph.D., will participate in a fireside chat at the Jefferies Global Healthcare Conference on June 4, 2025. A live webcast and archived version will be available on the company’s website. Abeona, a biopharmaceutical company, specializes in cell and gene therapies, with ZEVASKYN™ as its first and only autologous cell-based gene therapy for RDEB.
05-30 12:46
Cantor Fitzgerald Reiterates Overweight on Abeona Therapeutics, Maintains $18 Price Target
Cantor Fitzgerald analyst Kristen Kluska reiterates Abeona Therapeutics (NASDAQ:ABEO) with a Overweight and maintains $18 price target.
2024-09-20 23:09
